We facilitated a risk assessment for a small biotechnology start-up company, using an expanded risk analysis process. The outcomes allowed the company to set priorities for dealing with the risks it faced, improving controls and implementing assurance activities. Significantly, half of the most important risks had beneficial consequences.

Read the full case here.